| Ryan Edward Derby, MD | |
|
300 Pasteur Dr, Stanford, CA 94305-2200 | |
| (650) 723-4000 | |
| Not Available |
| Full Name | Ryan Edward Derby |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 18 Years |
| Location | 300 Pasteur Dr, Stanford, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306055231 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stanford Health Care | 6709797491 | 2572 |
News Archive
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes.
SunLink Health Systems, Inc. today announced that it expects its quarterly reports on Form 10-Q for the quarters ended September 30, 2008, December 31, 2008 and March 31, 2009, to be restated due to the impact of non-cash accounting errors at the Company's Carmichael's Cashway Pharmacy, Inc. subsidiary.
› Verified 8 days ago
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes.
SunLink Health Systems, Inc. today announced that it expects its quarterly reports on Form 10-Q for the quarters ended September 30, 2008, December 31, 2008 and March 31, 2009, to be restated due to the impact of non-cash accounting errors at the Company's Carmichael's Cashway Pharmacy, Inc. subsidiary.
› Verified 8 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes.
SunLink Health Systems, Inc. today announced that it expects its quarterly reports on Form 10-Q for the quarters ended September 30, 2008, December 31, 2008 and March 31, 2009, to be restated due to the impact of non-cash accounting errors at the Company's Carmichael's Cashway Pharmacy, Inc. subsidiary.
› Verified 8 days ago
| Entity Name | Bay Area Foot Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508911892 PECOS PAC ID: 0345329686 Enrollment ID: O20080512000353 |
News Archive
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes.
SunLink Health Systems, Inc. today announced that it expects its quarterly reports on Form 10-Q for the quarters ended September 30, 2008, December 31, 2008 and March 31, 2009, to be restated due to the impact of non-cash accounting errors at the Company's Carmichael's Cashway Pharmacy, Inc. subsidiary.
› Verified 8 days ago
| Entity Name | Ryan Derby, Md Corp. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154051308 PECOS PAC ID: 6800277328 Enrollment ID: O20220714003759 |
News Archive
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes.
SunLink Health Systems, Inc. today announced that it expects its quarterly reports on Form 10-Q for the quarters ended September 30, 2008, December 31, 2008 and March 31, 2009, to be restated due to the impact of non-cash accounting errors at the Company's Carmichael's Cashway Pharmacy, Inc. subsidiary.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Edward Derby, MD 300 Pasteur Dr, Stanford, CA 94305-2200 Ph: (650) 723-4000 | Ryan Edward Derby, MD 300 Pasteur Dr, Stanford, CA 94305-2200 Ph: (650) 723-4000 |
News Archive
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
Atrial fibrillation, which is the most common cardiac arrhythmia, is an important risk factor for strokes.
SunLink Health Systems, Inc. today announced that it expects its quarterly reports on Form 10-Q for the quarters ended September 30, 2008, December 31, 2008 and March 31, 2009, to be restated due to the impact of non-cash accounting errors at the Company's Carmichael's Cashway Pharmacy, Inc. subsidiary.
› Verified 8 days ago
Melissa Ann Vogelsong, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Room Hc435, Stanford, CA 94305 Phone: 650-723-4000 | |
Soniya Sharma, MD, FRCPC Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Dr. Isobel A. Russell, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Leland Hanowell, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, H3580 Mc 5640, Stanford, CA 94305 Phone: 650-723-6411 | |
Ronald Gary Pearl, MD, PHD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-5024 Fax: 650-725-0009 | |
Dr. Jesse Ephraim Goldmacher, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr Rm H3589, Stanford, CA 94305 Phone: 647-825-8726 Fax: 650-725-0009 | |
Cornel Chiu, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |